GRAL
GRAIL, LLC
NASDAQ: GRAL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$54.48
+9.64% today
Updated 2026-04-30
Market cap
$2.14B
P/E ratio
—
P/S ratio
14.55x
EPS (TTM)
$-11.11
Dividend yield
—
52W range
$30 – $119
Volume
1.4M
GRAIL, LLC (GRAL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-277.50%
Operating margin
-285.40%
ROE
-16.10%
ROA
-11.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-275.72M | — | — | — |
| 2019 | $0.00 | $-244.85M | — | — | — |
| 2020 | — | $-312.16M | — | — | — |
| 2021 | $14.61M | $-1.25B | -684.39% | -8,659.61% | -8,539.39% |
| 2022 | $55.55M | $-5.40B | -209.63% | -9,798.18% | -9,719.35% |
| 2023 | $93.11M | $-1.47B | -102.69% | -1,627.61% | -1,574.23% |
| 2024 | $125.59M | $-2.03B | -62.12% | -1,743.03% | -1,613.92% |
| 2025 | $147.17M | $-408.35M | -42.52% | -362.95% | -277.47% |